(Q54368796)

28 May 2018

title

Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to Pseudomonas aeruginosa. (English)

1 reference

28 May 2018

main subject

Pseudomonas aeruginosa

0 references

1 reference

C Thauvin

1

1 reference

28 May 2018

F Lecomte

2

1 reference

28 May 2018

I Le Boete

3

1 reference

28 May 2018

G Grise

4

1 reference

28 May 2018

J F Lemeland

5

1 reference

28 May 2018

publication date

1 January 1989

1 reference

28 May 2018

published in

Infection

1 reference

28 May 2018

volume

17

1 reference

28 May 2018

issue

1

1 reference

28 May 2018

page(s)

31-34

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1007/bf01643497

exact match

0 references

cites work

Method of reliable determination of minimal lethal antibiotic concentrations

1 reference

12 December 2020

In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent

1 reference

12 December 2020

Evaluation of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections.

1 reference

12 December 2020

Studies on antibiotic synergism against enterococci. I. Bacteriologic studies

1 reference

12 December 2020

Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits

1 reference

12 December 2020

Infective endocarditis caused by gram-negative bacteria: a review of the literature, 1945-1977.

1 reference

12 December 2020

Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo

1 reference

12 December 2020

Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis

1 reference

12 December 2020

The comparative in-vitro activity of eight newer quinolones and nalidixic acid.

1 reference

12 December 2020

Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats

1 reference

12 December 2020

Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosa

1 reference

12 December 2020

The role of Pseudomonas aeruginosa in infections.

1 reference

12 December 2020

Rat model of experimental endocarditis

1 reference

12 December 2020

Infections caused by Pseudomonas aeruginosa

1 reference

12 December 2020

Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa

1 reference

12 December 2020

Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections

1 reference

12 December 2020

Animal models: the in-vivo evaluation of ciprofloxacin

1 reference

12 December 2020

Use of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections

1 reference

12 December 2020

Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis

1 reference

12 December 2020

Long-term oral ciprofloxacin: experience in the treatment of incurable infective endocarditis.

1 reference

12 December 2020

Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia

1 reference

12 December 2020

Bactericidal activity of ciprofloxacin alone and in combination with azlocillin in an in-vitro capillary model.

1 reference

12 December 2020

In vitro activity of ciprofloxacin against aerobic gram-negative bacteria

1 reference

12 December 2020

Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosa

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01643497

1 reference

28 May 2018

1 reference

28 May 2018